Amna Nabeel Khan, MD, FACE, CCD
Endocrinology
Accepting new patients
Sees patients age 18 and up
Penn Endocrinology Perelman
Schedule onlineCall 215-662-2300
Penn Medicine Provider

About me

  • Co-Director, Penn Bone Center
  • Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)

Education and training

  • Medical School: King Edward Medical College
  • Residency: University of Tennessee Health Science Center
  • Residency: Long Island College Hospital
  • Fellowship: University of Tennessee Health Science Center

What my patients think about me

Average Rating

309 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
very detailed
October 2025
smart. caring. thorough
October 2025
very satisfied with my care
September 2025
very thorough, didn't rush, very nice interaction with me.

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Khan is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Marianne Riordan and Amna N. Khan Efficacy of Romosozumab After Long-Term Denosumab Therapy-A Case Report , Annual Meeting of Endocrine Society: 2025

Amna N. Khan, Robert B. Jones Jr, Nabeel Khan, Yu‑Xiao Yang, Robert A. Adler Trends in hip fracture rates in US male veterans , Osteoporosis International: 2024

Rashad Madi, Sarem Khan, Chamith S. Rajapakse, Amna N. Khan and Kate Temme Can Trabecular Bone score Enhance Fracture Risk Assessment in Long Distance Runners with bone Stress Injuries? , Clinical Journal of Sports Medicine: 2024

Amna N. Khan, MD, Jaliyah Johnson, BSN, Alexia Tsikouras, PharmD, Anna Zuschnitt, PharmD Reduction in the Non-adherence Rate to Denosumab Therapy with Clinical Pharmacy Collaboration: A Quality Improvement Project in an Osteoporosis Clinic , PRESENTED AT THE ANNUAL MEETING OF ASBMR IN VANCOUVER. OCTOBER: 2023

Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB. Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. , Eur Urol Oncol. 2023 Nov 3:S2588-9311(23)00230-4. doi: 10.1016/j.euo.2023.10.016: 2023

Khan AN, Jones RB, Khan N, Yang YX, Adler RA TRENDS IN HIP FRACTURE RATES IN MALE VETERANS , ANNUAL MEETING, ASBMR, VANCOUVER. OCT: 2023

Turin CG, Joeng KS, Kallish S, Raper A, Asher S, Campeau PM, Khan AN, Al Mukaddam M. Heterozygous variant in WNT1 gene in two brothers with early onset osteoporosis. , Bone Reports, 18 Aug 2021, 15(101118): 2021

Amna Khan Hypophosphatemia Associated with Intravenous Ferric Carboxymaltose Complicated by Multiple Insufficiency Fractures. , Presented virtually at the ASBMR Annual Meeting : 2020

Amna Khan Hypercalcemia Secondary to Calcitriol and PTHrp Cosecretion Only Responsive to Hydroxychloroquine , Presented virtually at ENDO 2020 Annual Meeting : 2020

Taher Modaressi, Michael Levine, Julia Tchou, Amna Khan. Gestational Gigantomastia Complicated By PTHrP-mediated Hypercalcemia , J Clin Endocrinol Metab, 103(9): 2018,3124-3130